Although expression of Rac1/Cdc42 in breast cancer specimens has been investigated previously, to the best of our knowledge, the current report is the first comprehensive analysis of the regulatory relationship between these angiogenesis molecules in breast cancer tissues. The gene discussed is CDC42; the disease is breast cancer.